Focus Group Interview Study on Patient Experiences and Satisfaction (RT_Focus)

Quality Improvement Actions on the Radiotherapy Ward: Focus Group Interview Study on Patient Experiences and Satisfaction

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members.

Study Overview

• Status: Withdrawn
• Conditions: Patient Satisfaction; Patient Preference
• Intervention / Treatment: Other: Focus group interview

Detailed Description

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members. Following research questions will be answered:

• What elements of care (ie infrastructure, interpersonal contact, information, communication) are good to the opinion of patients and family members?
• What elements of care can be improved?
• What are priorities in improvement of the care for patients and families?
• What actions could possibly be taken in order to improve the care for future patients?

Because the radiotherapy ward exists of 3 clusters, one per type of treatment conducted, the investigators will perform 6 focus group interviews with patients (3 in the French, and 3 in the Dutch language) and 6 focus group interviews with family members (3 in the French, and 3 in the Dutch language).

Investigators will collect sex, main diagnosis (of patients), age and nationality of all participants at the beginning of each focus group interview. They will transcribe all interviews verbatim and analyze them in Nvivo software as provided by the VUB. Participant characteristics will be analyzed by descriptive statistics.

• Study Type: Interventional
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Belgium
  • Brussel, Belgium, 1090
    • UZ Brussel

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion criteria for patients:

• Patients (18+) who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
• Dutch and French speaking
• Start date of treatment max 6 months before inclusion
• Estimated sample size: 5-8 x 6 patients

Inclusion criteria for family members:

• All family members (+18) of patients who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel
• Dutch and French speaking
• Start date of treatment of patient max 6 months before inclusion
• Estimated sample size: 5-8 x 6 family members

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Patient focus group; Patients who received radiation treatment	Other: Focus group interview; Group interview with patients who received radiation treatment
Experimental: Family focus group; Family of patients who received radiation treatment	Other: Focus group interview; Group interview with patients who received radiation treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of care	To identify elements of care that need improvement by using open ended interview questions and interaction between different participants	immediately after treatment
Problem solving	To identify solutions for problems in care by using open ended interview questions and interaction between different participants	immediately after treatment

Collaborators and Investigators

• Sponsor: Universitair Ziekenhuis Brussel

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2020
• Primary Completion (Estimated): September 1, 2021
• Study Completion (Estimated): December 1, 2021

Study Registration Dates

• First Submitted: March 5, 2020
• First Submitted That Met QC Criteria: November 6, 2020
• First Posted (Actual): November 12, 2020

Study Record Updates

• Last Update Posted (Actual): May 28, 2024
• Last Update Submitted That Met QC Criteria: May 24, 2024
• Last Verified: May 1, 2024

More Information

Terms related to this study

• Keywords: Quality of care
• Other Study ID Numbers: 2020-087

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No